Cargando…
Outcomes of relapsed or refractory acute myeloid leukemia after front-line hypomethylating agent and venetoclax regimens
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Fondazione Ferrata Storti
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7927994/ https://www.ncbi.nlm.nih.gov/pubmed/32499238 http://dx.doi.org/10.3324/haematol.2020.252569 |
| _version_ | 1783659772126429184 |
|---|---|
| author | Maiti, Abhishek Rausch, Caitlin R. Cortes, Jorge E. Pemmaraju, Naveen Daver, Naval G. Ravandi, Farhad Garcia-Manero, Guillermo Borthakur, Gautam Naqvi, Kiran Ohanian, Maro Short, Nicholas J. Alvarado, Yesid Kadia, Tapan M. Takahashi, Koichi Yilmaz, Musa Jain, Nitin Kornblau, Steven Montalban-Bravo, Guillermo Sasaki, Koji Andreeff, Michael Bose, Prithviraj Ferrajoli, Alessandra Issa, Ghayas C. Jabbour, Elias J. Masarova, Lucia Thompson, Philip A. Wang, Sa Konoplev, Sergej Pierce, Sherry A. Ning, Jing Qiao, Wei Welch, John S. Kantarjian, Hagop M. DiNardo, Courtney D. Konopleva, Marina Y. |
| author_facet | Maiti, Abhishek Rausch, Caitlin R. Cortes, Jorge E. Pemmaraju, Naveen Daver, Naval G. Ravandi, Farhad Garcia-Manero, Guillermo Borthakur, Gautam Naqvi, Kiran Ohanian, Maro Short, Nicholas J. Alvarado, Yesid Kadia, Tapan M. Takahashi, Koichi Yilmaz, Musa Jain, Nitin Kornblau, Steven Montalban-Bravo, Guillermo Sasaki, Koji Andreeff, Michael Bose, Prithviraj Ferrajoli, Alessandra Issa, Ghayas C. Jabbour, Elias J. Masarova, Lucia Thompson, Philip A. Wang, Sa Konoplev, Sergej Pierce, Sherry A. Ning, Jing Qiao, Wei Welch, John S. Kantarjian, Hagop M. DiNardo, Courtney D. Konopleva, Marina Y. |
| author_sort | Maiti, Abhishek |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7927994 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Fondazione Ferrata Storti |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-79279942021-03-05 Outcomes of relapsed or refractory acute myeloid leukemia after front-line hypomethylating agent and venetoclax regimens Maiti, Abhishek Rausch, Caitlin R. Cortes, Jorge E. Pemmaraju, Naveen Daver, Naval G. Ravandi, Farhad Garcia-Manero, Guillermo Borthakur, Gautam Naqvi, Kiran Ohanian, Maro Short, Nicholas J. Alvarado, Yesid Kadia, Tapan M. Takahashi, Koichi Yilmaz, Musa Jain, Nitin Kornblau, Steven Montalban-Bravo, Guillermo Sasaki, Koji Andreeff, Michael Bose, Prithviraj Ferrajoli, Alessandra Issa, Ghayas C. Jabbour, Elias J. Masarova, Lucia Thompson, Philip A. Wang, Sa Konoplev, Sergej Pierce, Sherry A. Ning, Jing Qiao, Wei Welch, John S. Kantarjian, Hagop M. DiNardo, Courtney D. Konopleva, Marina Y. Haematologica Letters to the Editor Fondazione Ferrata Storti 2020-06-04 /pmc/articles/PMC7927994/ /pubmed/32499238 http://dx.doi.org/10.3324/haematol.2020.252569 Text en Copyright© 2021 Ferrata Storti Foundation http://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. |
| spellingShingle | Letters to the Editor Maiti, Abhishek Rausch, Caitlin R. Cortes, Jorge E. Pemmaraju, Naveen Daver, Naval G. Ravandi, Farhad Garcia-Manero, Guillermo Borthakur, Gautam Naqvi, Kiran Ohanian, Maro Short, Nicholas J. Alvarado, Yesid Kadia, Tapan M. Takahashi, Koichi Yilmaz, Musa Jain, Nitin Kornblau, Steven Montalban-Bravo, Guillermo Sasaki, Koji Andreeff, Michael Bose, Prithviraj Ferrajoli, Alessandra Issa, Ghayas C. Jabbour, Elias J. Masarova, Lucia Thompson, Philip A. Wang, Sa Konoplev, Sergej Pierce, Sherry A. Ning, Jing Qiao, Wei Welch, John S. Kantarjian, Hagop M. DiNardo, Courtney D. Konopleva, Marina Y. Outcomes of relapsed or refractory acute myeloid leukemia after front-line hypomethylating agent and venetoclax regimens |
| title | Outcomes of relapsed or refractory acute myeloid leukemia after front-line hypomethylating agent and venetoclax regimens |
| title_full | Outcomes of relapsed or refractory acute myeloid leukemia after front-line hypomethylating agent and venetoclax regimens |
| title_fullStr | Outcomes of relapsed or refractory acute myeloid leukemia after front-line hypomethylating agent and venetoclax regimens |
| title_full_unstemmed | Outcomes of relapsed or refractory acute myeloid leukemia after front-line hypomethylating agent and venetoclax regimens |
| title_short | Outcomes of relapsed or refractory acute myeloid leukemia after front-line hypomethylating agent and venetoclax regimens |
| title_sort | outcomes of relapsed or refractory acute myeloid leukemia after front-line hypomethylating agent and venetoclax regimens |
| topic | Letters to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7927994/ https://www.ncbi.nlm.nih.gov/pubmed/32499238 http://dx.doi.org/10.3324/haematol.2020.252569 |
| work_keys_str_mv | AT maitiabhishek outcomesofrelapsedorrefractoryacutemyeloidleukemiaafterfrontlinehypomethylatingagentandvenetoclaxregimens AT rauschcaitlinr outcomesofrelapsedorrefractoryacutemyeloidleukemiaafterfrontlinehypomethylatingagentandvenetoclaxregimens AT cortesjorgee outcomesofrelapsedorrefractoryacutemyeloidleukemiaafterfrontlinehypomethylatingagentandvenetoclaxregimens AT pemmarajunaveen outcomesofrelapsedorrefractoryacutemyeloidleukemiaafterfrontlinehypomethylatingagentandvenetoclaxregimens AT davernavalg outcomesofrelapsedorrefractoryacutemyeloidleukemiaafterfrontlinehypomethylatingagentandvenetoclaxregimens AT ravandifarhad outcomesofrelapsedorrefractoryacutemyeloidleukemiaafterfrontlinehypomethylatingagentandvenetoclaxregimens AT garciamaneroguillermo outcomesofrelapsedorrefractoryacutemyeloidleukemiaafterfrontlinehypomethylatingagentandvenetoclaxregimens AT borthakurgautam outcomesofrelapsedorrefractoryacutemyeloidleukemiaafterfrontlinehypomethylatingagentandvenetoclaxregimens AT naqvikiran outcomesofrelapsedorrefractoryacutemyeloidleukemiaafterfrontlinehypomethylatingagentandvenetoclaxregimens AT ohanianmaro outcomesofrelapsedorrefractoryacutemyeloidleukemiaafterfrontlinehypomethylatingagentandvenetoclaxregimens AT shortnicholasj outcomesofrelapsedorrefractoryacutemyeloidleukemiaafterfrontlinehypomethylatingagentandvenetoclaxregimens AT alvaradoyesid outcomesofrelapsedorrefractoryacutemyeloidleukemiaafterfrontlinehypomethylatingagentandvenetoclaxregimens AT kadiatapanm outcomesofrelapsedorrefractoryacutemyeloidleukemiaafterfrontlinehypomethylatingagentandvenetoclaxregimens AT takahashikoichi outcomesofrelapsedorrefractoryacutemyeloidleukemiaafterfrontlinehypomethylatingagentandvenetoclaxregimens AT yilmazmusa outcomesofrelapsedorrefractoryacutemyeloidleukemiaafterfrontlinehypomethylatingagentandvenetoclaxregimens AT jainnitin outcomesofrelapsedorrefractoryacutemyeloidleukemiaafterfrontlinehypomethylatingagentandvenetoclaxregimens AT kornblausteven outcomesofrelapsedorrefractoryacutemyeloidleukemiaafterfrontlinehypomethylatingagentandvenetoclaxregimens AT montalbanbravoguillermo outcomesofrelapsedorrefractoryacutemyeloidleukemiaafterfrontlinehypomethylatingagentandvenetoclaxregimens AT sasakikoji outcomesofrelapsedorrefractoryacutemyeloidleukemiaafterfrontlinehypomethylatingagentandvenetoclaxregimens AT andreeffmichael outcomesofrelapsedorrefractoryacutemyeloidleukemiaafterfrontlinehypomethylatingagentandvenetoclaxregimens AT boseprithviraj outcomesofrelapsedorrefractoryacutemyeloidleukemiaafterfrontlinehypomethylatingagentandvenetoclaxregimens AT ferrajolialessandra outcomesofrelapsedorrefractoryacutemyeloidleukemiaafterfrontlinehypomethylatingagentandvenetoclaxregimens AT issaghayasc outcomesofrelapsedorrefractoryacutemyeloidleukemiaafterfrontlinehypomethylatingagentandvenetoclaxregimens AT jabboureliasj outcomesofrelapsedorrefractoryacutemyeloidleukemiaafterfrontlinehypomethylatingagentandvenetoclaxregimens AT masarovalucia outcomesofrelapsedorrefractoryacutemyeloidleukemiaafterfrontlinehypomethylatingagentandvenetoclaxregimens AT thompsonphilipa outcomesofrelapsedorrefractoryacutemyeloidleukemiaafterfrontlinehypomethylatingagentandvenetoclaxregimens AT wangsa outcomesofrelapsedorrefractoryacutemyeloidleukemiaafterfrontlinehypomethylatingagentandvenetoclaxregimens AT konoplevsergej outcomesofrelapsedorrefractoryacutemyeloidleukemiaafterfrontlinehypomethylatingagentandvenetoclaxregimens AT piercesherrya outcomesofrelapsedorrefractoryacutemyeloidleukemiaafterfrontlinehypomethylatingagentandvenetoclaxregimens AT ningjing outcomesofrelapsedorrefractoryacutemyeloidleukemiaafterfrontlinehypomethylatingagentandvenetoclaxregimens AT qiaowei outcomesofrelapsedorrefractoryacutemyeloidleukemiaafterfrontlinehypomethylatingagentandvenetoclaxregimens AT welchjohns outcomesofrelapsedorrefractoryacutemyeloidleukemiaafterfrontlinehypomethylatingagentandvenetoclaxregimens AT kantarjianhagopm outcomesofrelapsedorrefractoryacutemyeloidleukemiaafterfrontlinehypomethylatingagentandvenetoclaxregimens AT dinardocourtneyd outcomesofrelapsedorrefractoryacutemyeloidleukemiaafterfrontlinehypomethylatingagentandvenetoclaxregimens AT konoplevamarinay outcomesofrelapsedorrefractoryacutemyeloidleukemiaafterfrontlinehypomethylatingagentandvenetoclaxregimens |